MedTrace Logo

Early Progressive Strength Exercise for Treatment of Acute Achilles Tendon Rupture.

NCT04726189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2024-06-24

No results posted yet for this study

Summary

The purpose of this trial is to investigate the efficacy of standard care versus standard care combined with an early progressive exercise program in improving the function of the tendon and leg muscles after non-surgical treated Achilles tendon rupture

Conditions

  • Achilles Tendon Rupture

Interventions

OTHER

Standard exercises

Consists of a a standard exercise program with range of motion exercises from the third week and elastic band exercise from the sixth week.

OTHER

Standard exercises plus Early progressive exercises

This exercise program consists of standard exercises plus the early progressive program that initiates early (second week) and continues with resistance exercises with progression of the load according to individual participant toleration. Exercises are isometric exercises from the second week and then gradually progression of load in seated heel-rise and resistance band exercises.

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Marianne Christensen, MHSc · Aalborg University Hospital, Denmark

  • Inge Lunding Kjær, MD · Aalborg University Hospital, Denmark

  • Jennifer A Zellers, PhD · Washington University School of Medicine in St. Louis, USA

  • Karin Grävare Silbernagel, PhD · University of Delaware, DE USA

  • Michael Skovdal Rathleff, PhD · Aalborg University Hospital, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2023-01-30
Completion
2023-11-23

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04726189 on ClinicalTrials.gov